MCM
ELOS

Manchester Capital Management’s Syneron Medical Ltd ELOS Stock Holding History

Manchester Capital Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-9,618
Closed -$70K – 595
2016
Q1 		$70K Buy
+9,618
New +$68.9K 0.01% 383

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Manchester Capital Management's ELOS Position: Q2 2016 in Review

Manchester Capital Management sold out of Syneron Medical Ltd (ELOS) in Q2 2016, closing a stake of 9,618 shares — an estimated $70K sold.

Manchester Capital Management first reported a position in ELOS in Q1 2016 and held it in 1 quarter. The position peaked at $70K in Q1 2016. 65 funds tracked by Wall St. Rank hold ELOS as of Q2 2016.

  • Manchester Capital Management reported no remaining Syneron Medical Ltd position as of Q2 2016 after selling out during the quarter.
  • Manchester Capital Management sold 9,618 Syneron Medical Ltd shares in Q2 2016, an estimated $70K.
  • Manchester Capital Management first reported a position in Syneron Medical Ltd in Q1 2016 and held it in 1 quarter.
  • Manchester Capital Management's Syneron Medical Ltd position peaked at $70K in Q1 2016.
  • 65 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2016.

Based on Manchester Capital Management's 13F filing for Q2 2016, filed 20 Jul 2016.